• ქართული
  • English
  • Roche says $4.3 billion Spark offer still on track for June completion

    Roche Holding said its effort to expand in gene therapy via the $4.3 billion takeover of Spark Therapeutics remained on track despite failing to get enough votes to clinch the deal and as U.S. regulators continued scrutinizing it.

    Market Quotes by TradingView